risedronate sodium · Medicine question

Is the Aspire Pharma Ltd product risedronate sodium 35 mg film-coated tablets indicated for osteoporosis in men at high risk of fractures?

Name: Is the Aspire Pharma Ltd product risedronate sodium 35 mg film-coated tablets indicated for osteoporosis in men at high risk of fractures?
Published: 2026-11-08T02:01:55.882Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, the Aspire Pharma Ltd product risedronate sodium 35 mg film-coated tablets is indicated for treatment of osteoporosis in men at high risk of fractures.

Sources for this answer

Risedronate sodium 35 mg film-coated tabletsAspire Pharma Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated 28 January 2019

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about risedronate sodium